论文部分内容阅读
通过对HBsAg阳性志愿者接种甲型肝炎减毒活疫苗的抗体应答及其它有关临床反应观察，表明HBsAg阳性者接种甲肝减毒活疫苗后，其局部及全身临床反应与对照组差异无显著意义，肝酶检测2、4、8周（SGPT）与免疫前相对照，未见有意义的改变，但却能同样地产生良好的抗体反应，两组抗体水平相似。证实甲肝减毒活疫苗不仅可对此类易感人群接种，还可提供同样的保护。
Through the HBsAg positive volunteers vaccinated with attenuated live attenuated hepatitis A vaccine and other clinical response to the observation that the HBsAg-positive live attenuated live attenuated hepatitis A vaccine, the local and systemic clinical response and the control group no significant difference, There was no significant change at 2, 4, 8 weeks (SGPT) compared with pre-immunization, but it could produce good antibody response in the same way. The antibody levels of the two groups were similar. Confirmed live attenuated hepatitis A vaccine can not only vaccinate such susceptible populations, but also provide the same protection.